INTERPHARM CONSULTANCY is an independent consultancy service specialising in the commercial aspects of generics with more than 30 years' pharmaceutical experience. 

Peter later joined the Indian generic leader Ranbaxy to help set up its UK business and then returned to consultancy work - see website at (http://www.interpharm-consultancy.co.uk/). Interpharm is therefore able to provide help and advice on the basis of extensive generic industry experience.

 Amongst its services, INTERPHARM:

• helps with business development, 

• advises new market entrants on generic strategies,
  

• assists with product licensing,
  

• helps companies seeking to enlarge their product portfolios
  

• acts as an agent for a CRO providing biostudies to the generic industry.
  

 In addition, Peter has written a number of reports on the generics industry including "Growth Strategies in Generics"," Generics Defense Strategies" and "US and European Prescription Generic Markets" and is a regular contributor to the GenericsWeb newsletter "INNsight".

The European Union (EU) is expanding to include new members and with its expansion the opportunities for generic pharmaceuticals are growing too. With Bulgaria and Romania intending to join the EU in 2007, now is a verygood time for you to look at opportunities for your company in the EU.

Competitor companies from India, China and several other East European countries are already moving into the European marketplace. Others are sure to follow soon.

It is therefore important for companies interested in this market to act now in order to gain market share.

Western Europe is a challenging market despite the new legislation designed to increase harmonisation between markets. Many differences still exist between countries due to their history and pharmaceuticalenvironments. These can be very difficult to understand for companies coming from outside the EU and a reliable guide is necessary

There is a solution - take the initiative now and look at establishing yourself in Europe either through a subsidiary or finding a distributor for your products. But where should new market entrants start?

Interpharm can help you find answers to this question.

Interpharm offers you:

· In-depth knowledge of the European generic industry

· Experience of establishing new generic business in Europe

· Experience of working with East European pharmaceutical companies

·Up to date knowledge of the latest European pharmaceutical legislation

· Extensive contacts with the major players in the European generic industry

· Guidance of how the West European generic environment differs from that which you know

We can be your bridge to Western Europe, allowing you to take advantage of the increasing levels of cross-border harmonisation. European generics are going through a major growth phase right now. You can take advantage of this opportunity before your competitors spot what is happening.Contact us now for more information. 

• Jacobsen Pharma A/S (20/07/2010)
• Pharma Marketing 2010 (20/07/2010)
• Achieving preferential patient-access through innovative agreements with payers (09/07/2010)

• GenericsWeb (01/03/2006)